BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1386 related articles for article (PubMed ID: 11254382)

  • 21. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding.
    Kurokawa R; DiRenzo J; Boehm M; Sugarman J; Gloss B; Rosenfeld MG; Heyman RA; Glass CK
    Nature; 1994 Oct; 371(6497):528-31. PubMed ID: 7935766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
    Bouton D; Escriva H; de Mendonça RL; Glineur C; Bertin B; Noël C; Robinson-Rechavi M; de Groot A; Cornette J; Laudet V; Pierce RJ
    J Mol Endocrinol; 2005 Apr; 34(2):567-82. PubMed ID: 15821117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
    Sato Y; Ramalanjaona N; Huet T; Potier N; Osz J; Antony P; Peluso-Iltis C; Poussin-Courmontagne P; Ennifar E; Mély Y; Dejaegere A; Moras D; Rochel N
    PLoS One; 2010 Nov; 5(11):e15119. PubMed ID: 21152046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
    Dey A; Ozato K
    Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polarity-specific activities of retinoic acid receptors determined by a co-repressor.
    Kurokawa R; Söderström M; Hörlein A; Halachmi S; Brown M; Rosenfeld MG; Glass CK
    Nature; 1995 Oct; 377(6548):451-4. PubMed ID: 7566126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha.
    Bourguet W; Ruff M; Chambon P; Gronemeyer H; Moras D
    Nature; 1995 Jun; 375(6530):377-82. PubMed ID: 7760929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
    Figueira AC; Dias SM; Santos MA; Apriletti JW; Baxter JD; Webb P; Neves FA; Simeoni LA; Ribeiro RC; Polikarpov I
    Cell Biochem Biophys; 2006; 44(3):453-62. PubMed ID: 16679533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.
    Angulo A; Suto C; Heyman RA; Ghazal P
    Mol Endocrinol; 1996 Jul; 10(7):781-93. PubMed ID: 8813719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors.
    Perlmann T; Umesono K; Rangarajan PN; Forman BM; Evans RM
    Mol Endocrinol; 1996 Aug; 10(8):958-66. PubMed ID: 8843412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140.
    Chen Y; Hu X; Wei LN
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):43-50. PubMed ID: 15489004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5).
    Xiao JH; Durand B; Chambon P; Voorhees JJ
    J Biol Chem; 1995 Feb; 270(7):3001-11. PubMed ID: 7852380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry.
    Chen X; Tordova M; Gilliland GL; Wang L; Li Y; Yan H; Ji X
    J Mol Biol; 1998 May; 278(3):641-53. PubMed ID: 9600845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
    Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-resolution structures of thyroid hormone receptor dimers and tetramers in solution.
    Figueira AC; Neto Mde O; Bernardes A; Dias SM; Craievich AF; Baxter JD; Webb P; Polikarpov I
    Biochemistry; 2007 Feb; 46(5):1273-83. PubMed ID: 17260956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers.
    Iyer J; Bonnier D; Granger F; Iltis C; Andry V; Schultz P; Gronemeyer H
    Protein Expr Purif; 1999 Jul; 16(2):308-14. PubMed ID: 10419826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution solution structure of the retinoid X receptor DNA-binding domain.
    Holmbeck SM; Foster MP; Casimiro DR; Sem DS; Dyson HJ; Wright PE
    J Mol Biol; 1998 Aug; 281(2):271-84. PubMed ID: 9698548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
    Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.